Jeil Pharma Holdings Inc (002620.KS)
KRW 7990.0
(-3.5%)
KRW 7990.0
(-3.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.41 Billion | -20.8 Billion | 13.4 Billion | -23.67 Billion | 25.21 Billion | -3.43 Billion |
| Net Income | -16.24 Billion | -83.14 Billion | -12.87 Billion | 14.94 Billion | -95.85 Billion | 7.3 Billion |
| Depreciation & Amortization | 12.55 Billion | 10.9 Billion | 8.98 Billion | 8.65 Billion | 7.78 Billion | 1.65 Billion |
| Deferred income taxes | -60.63 Billion | - | -663.95 Million | -6.02 Billion | - | - |
| Stock-based compensation | 578.02 Million | 472.48 Million | 163.16 Million | 80.04 Million | - | - |
| Change in working capital | -28.54 Billion | -22.11 Billion | 14.4 Billion | -44.67 Billion | 14.69 Billion | -9.24 Billion |
| Other non-cash items | 87.87 Billion | 73.08 Billion | 3.38 Billion | 3.35 Billion | 98.59 Billion | -3.14 Billion |
| Investing Cash Flow | -13.42 Billion | -17.56 Billion | 7.32 Billion | -1.6 Billion | -40.84 Billion | -46.95 Billion |
| Investments in PPE | -9.83 Billion | -21.41 Billion | -23.73 Billion | -10.26 Billion | -1.65 Billion | -1.43 Billion |
| Acquisitions | 87.63 Million | 23.98 Million | -1.49 Billion | 6.93 Billion | -33.13 Billion | 17.01 Million |
| Investment purchases | -3.76 Billion | -273.49 Thousand | -10 Billion | -22.19 Billion | -28.49 Billion | -7.89 Billion |
| Sales/Maturities of investments | - | 169.68 Million | 999.52 Million | 20.05 Billion | 22.09 Billion | 8.12 Billion |
| Other Investing Activities | 93.8 Million | 3.65 Billion | 41.56 Billion | 3.86 Billion | 345.8 Million | -45.76 Billion |
| Financing Cash Flow | 20.61 Billion | 44.91 Billion | -12.23 Billion | 24.89 Billion | -3.88 Billion | 77.67 Billion |
| Debt repayment | -22.63 Billion | -5.15 Billion | -6.12 Billion | -11.12 Billion | -77.07 Billion | -77.89 Billion |
| Dividends payments | -1.13 Billion | -1.47 Billion | -1.59 Billion | -1.58 Billion | -1.52 Billion | -223.31 Million |
| Common Stock Repurchased | - | -396.98 Million | -31.21 Billion | 37.88 Billion | - | - |
| Common Stock Issuance | - | - | 7.49 Billion | 37.91 Million | - | - |
| Other Financing Activities | 44.38 Billion | 51.94 Billion | 19.18 Billion | -314.87 Million | 74.7 Billion | 77.89 Billion |
| Accounts receivables | -12.92 Billion | -14.12 Billion | 8.02 Billion | 4.99 Billion | 8.29 Billion | -6.89 Billion |
| Accounts payables | -9.84 Billion | 3.35 Billion | 10.02 Billion | -8.55 Billion | 6.38 Billion | -1.04 Billion |
| Inventory | -12.17 Billion | 1.34 Billion | 9.34 Billion | -28.71 Billion | 588.9 Million | -7.3 Billion |
| Other working capital | 6.39 Billion | -12.69 Billion | -12.98 Billion | -12.39 Billion | -581.53 Million | -1.94 Billion |
| Cash at beginning of period | 34.75 Billion | 28.58 Billion | 20.18 Billion | 21.23 Billion | 41.09 Billion | 8.75 Billion |
| Cash at end of period | 37.03 Billion | 34.75 Billion | 28.58 Billion | 20.18 Billion | 21.23 Billion | 41.09 Billion |
| Capital Expenditure | -9.83 Billion | -21.41 Billion | -23.73 Billion | -10.26 Billion | -1.65 Billion | -1.43 Billion |
| Effect of forex changes on cash | -496.29 Million | -369.36 Million | -93.19 Million | -669.65 Million | -341.69 Million | 6.36 Million |
| Net cash flow / Change in cash | 2.27 Billion | 6.17 Billion | 8.39 Billion | -1.05 Billion | -19.86 Billion | 32.34 Billion |
| Free Cash Flow | -14.25 Billion | -42.21 Billion | -10.33 Billion | -33.93 Billion | 23.55 Billion | -4.87 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.26 Billion | 44.42 Million | -27.05 Billion | -16.24 Billion | -2.84 Billion | 175.32 Million |
| Depreciation & Amortization | 3.6 Billion | 3.37 Billion | 3.26 Billion | 12.55 Billion | 3.09 Billion | 3.15 Billion |
| Deferred income taxes | - | - | -2.22 Billion | -60.63 Billion | -3.45 Billion | -2.87 Billion |
| Stock-based compensation | - | 213.55 Million | 26.69 Million | 578.02 Million | 233.46 Million | 224.55 Million |
| Change in working capital | -9.42 Billion | 138.15 Million | 10.16 Billion | -28.54 Billion | -15.28 Billion | 9.01 Billion |
| Other non-cash items | 17.9 Billion | 2.92 Billion | 29.15 Billion | 87.87 Billion | 2.33 Billion | 2.27 Billion |
| Investing Cash Flow | 6.06 Billion | -1.77 Billion | 1.4 Billion | -13.42 Billion | -1.96 Billion | -15.57 Billion |
| Investments in PPE | -647.88 Million | -1.92 Billion | -2.74 Billion | -9.83 Billion | -1.83 Billion | -1.98 Billion |
| Acquisitions | 6.35 Million | - | 14.63 Million | 87.63 Million | - | 67 Million |
| Investment purchases | 181.06 Million | -188.96 Million | 4.04 Billion | -3.76 Billion | -130.26 Million | -7.67 Billion |
| Sales/Maturities of investments | 7.8 Billion | - | - | - | - | -6.05 Billion |
| Other Investing Activities | 6.71 Billion | 340 Million | 92.8 Million | 93.8 Million | 1 Million | 78.16 Million |
| Financing Cash Flow | -5.84 Billion | -3.66 Billion | -11.54 Billion | 20.61 Billion | 9.29 Billion | 13.25 Billion |
| Debt repayment | -910.74 Million | -3.43 Billion | -8.11 Billion | -22.63 Billion | -6.67 Billion | -14.56 Billion |
| Dividends payments | -767.3 Million | - | - | -1.13 Billion | -362 Million | -1.49 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.8 Billion | - | -3.42 Billion | 44.38 Billion | 16.33 Billion | 29.31 Billion |
| Accounts receivables | -10.64 Billion | 4.78 Billion | -22.51 Million | -12.92 Billion | -14.84 Billion | 18.17 Billion |
| Accounts payables | -2.59 Billion | 4.38 Billion | -11.84 Billion | -9.84 Billion | 11.82 Billion | -9.51 Billion |
| Inventory | -1.52 Billion | -7.61 Billion | 16.2 Billion | -12.17 Billion | -8.75 Billion | -365.75 Million |
| Other working capital | 2.73 Billion | -1.41 Billion | 5.82 Billion | 6.39 Billion | -3.5 Billion | 722.03 Million |
| Cash at beginning of period | 33.45 Billion | 37.03 Billion | 34.53 Billion | 34.75 Billion | 43.04 Billion | 33.29 Billion |
| Cash at end of period | 33.57 Billion | 33.45 Billion | 37.03 Billion | 37.03 Billion | 34.53 Billion | 43.04 Billion |
| Capital Expenditure | -647.88 Million | -1.92 Billion | -2.74 Billion | -9.83 Billion | -1.83 Billion | -1.98 Billion |
| Effect of forex changes on cash | 83.14 Million | 568.19 Million | -683.86 Million | -496.29 Million | 81.17 Million | 91.48 Million |
| Net cash flow / Change in cash | 122.97 Million | -3.58 Billion | 2.5 Billion | 2.27 Billion | -8.5 Billion | 9.74 Billion |
| Free Cash Flow | -832.06 Million | -641.31 Million | 10.58 Billion | -14.25 Billion | -17.75 Billion | 9.98 Billion |
AMLLF
RISHABH
EICCF
JLHL
1033
002926